NY Weight Loss Drug Lawsuits: Ozempic

The Rise of GLP-1 Weight Loss Drugs

Medications like Ozempic (semaglutide), Wegovy (semaglutide), Saxenda (liraglutide), Mounjaro (tirzepatide), Rybelsus (oral semaglutide), and Trulicity (dulaglutide) have revolutionized weight loss and diabetes treatment. However, thousands of patients nationwide, including many in New York, have experienced severe, unexpected side effects.

At Licatesi Law Group, we're investigating weight loss drug injury claims for New York residents who've suffered serious complications from these medications. If you've experienced gastroparesis, bowel obstruction, or other severe side effects, you may be entitled to compensation.

What Are GLP-1 Receptor Agonists?

GLP-1 (glucagon-like peptide-1) receptor agonists are medications that mimic a natural hormone that regulates blood sugar and appetite. Originally developed for type 2 diabetes, these drugs became popular for weight loss due to their appetite-suppressing effects.

Common GLP-1 Medications

• Ozempic (semaglutide) - FDA approved for type 2 diabetes
• Wegovy (semaglutide) - FDA approved for weight loss
• Saxenda (liraglutide) - FDA approved for weight loss
• Mounjaro (tirzepatide) - FDA approved for type 2 diabetes
• Zepbound (tirzepatide) - FDA approved for weight loss
• Rybelsus (oral semaglutide) - FDA approved for type 2 diabetes
• Trulicity (dulaglutide) - FDA approved for type 2 diabetes

Serious Side Effects and Complications

While manufacturers marketed these drugs as safe and effective, emerging evidence reveals serious, potentially permanent complications.

Gastroparesis (Stomach Paralysis)

Gastroparesis is a condition where the stomach cannot empty properly. Symptoms include:

• Severe nausea and vomiting
• Feeling full after eating small amounts
• Chronic abdominal pain
• Acid reflux and heartburn
• Malnutrition and weight loss
• Unpredictable blood sugar levels

Important: Some patients report gastroparesis symptoms persisting even after stopping the medication, suggesting permanent damage.

Bowel Obstructions

GLP-1 drugs can slow intestinal movement, leading to dangerous blockages requiring emergency surgery.

Gallbladder Disease

Rapid weight loss from these medications increases gallstone formation, leading to:

• Acute cholecystitis (gallbladder inflammation)
• Gallstones requiring surgery
• Bile duct obstructions

Pancreatitis

Inflammation of the pancreas causing severe abdominal pain, nausea, and potential organ failure.

Additional Reported Side Effects

• Kidney problems and kidney failure
• Vision changes (diabetic retinopathy)
• Thyroid tumors (seen in animal studies)
• Severe dehydration
• Suicidal ideation (under investigation)

Why Are Weight Loss Drug Lawsuits Being Filed?

Plaintiffs allege that manufacturers:

Failed to Adequately Warn

Drug makers knew or should have known about serious gastrointestinal risks but failed to provide adequate warnings to patients and doctors.

Downplayed Severity of Side Effects

Marketing materials emphasized benefits while minimizing risks, leading patients to make uninformed decisions.

Continued Marketing Despite Known Risks

Even as reports of serious complications increased, companies continued aggressive marketing campaigns.

What is the Legal Basis for These Lawsuits?

Product Liability Claims

• Design Defects: The drugs are inherently dangerous due to their mechanism of action
• Failure to Warn: Inadequate warnings about serious gastrointestinal risks
• Negligent Marketing: Misleading promotion that downplayed risks

Breach of Warranty

Manufacturers represented these drugs as safe and effective for weight loss when they pose serious, undisclosed risks.

Current Status of Weight Loss Drug Litigation

As of 2025, hundreds of lawsuits have been filed in federal courts nationwide. Legal experts anticipate these cases may be consolidated into Multi-District Litigation (MDL) for coordinated pre-trial proceedings.

Manufacturers Facing Lawsuits

• Novo Nordisk (Ozempic, Wegovy, Rybelsus, Saxenda)
• Eli Lilly (Mounjaro, Zepbound, Trulicity)

Who Qualifies for a Weight Loss Drug Lawsuit?

You may have a claim if:

• You took Ozempic, Wegovy, Saxenda, Mounjaro, Zepbound, Rybelsus, or Trulicity
• You developed gastroparesis, bowel obstruction, gallbladder disease, or pancreatitis
• You required hospitalization or surgery for complications
• Your symptoms persist even after stopping the medication
• You suffered significant medical expenses and lost wages

Compensation Available in Weight Loss Drug Lawsuits

Successful claims may recover:

• Medical expenses - Past and future treatment costs
• Lost wages - Income lost due to illness and treatment
• Pain and suffering - Physical and emotional distress
• Loss of enjoyment of life - Inability to participate in normal activities
• Punitive damages - Penalties against manufacturers for wrongful conduct

Why Choose Licatesi Law Group for Your Weight Loss Drug Case

For over 40 years, we've represented New York residents in complex product liability and pharmaceutical litigation. Our attorneys have the experience and resources to take on large pharmaceutical companies.

Our Approach

• Thorough medical record review and case evaluation
• Consultation with medical experts on causation
• Aggressive pursuit of maximum compensation
• No fees unless we win your case

What to Do If You've Been Injured

1. Seek immediate medical attention for severe symptoms
2. Document everything - medical records, prescriptions, symptoms
3. Do not destroy medication - keep bottles, packaging, and prescription information
4. Report adverse events to your doctor and FDA MedWatch
5. Consult with an attorney before signing any releases or settlements

If you or a loved one suffered serious complications from Ozempic, Wegovy, Saxenda, Mounjaro, or other GLP-1 medications, contact Licatesi Law Group for a free, confidential case evaluation. Call (516) 227-2662. Available 24/7.